250 related articles for article (PubMed ID: 18694595)
1. A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies.
Zhang X; He H; Yen C; Ho W; Lee LJ
Biomaterials; 2008 Nov; 29(31):4253-9. PubMed ID: 18694595
[TBL] [Abstract][Full Text] [Related]
2. Superior cell delivery features of poly(ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules.
Haque T; Chen H; Ouyang W; Martoni C; Lawuyi B; Urbanska AM; Prakash S
Mol Pharm; 2005; 2(1):29-36. PubMed ID: 15804175
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility and membrane strength of C3H10T1/2 cell-loaded alginate-based microcapsules.
Zhang WJ; Li BG; Zhang C; Xie XH; Tang TT
Cytotherapy; 2008; 10(1):90-7. PubMed ID: 18202978
[TBL] [Abstract][Full Text] [Related]
4. A naonoporous cell-therapy device with controllable biodegradation for long-term drug release.
He H; Luedke E; Zhang X; Yu B; Schmitt A; McClarren B; Grignol V; Carson WE; Lee LJ
J Control Release; 2013 Feb; 165(3):226-33. PubMed ID: 23228849
[TBL] [Abstract][Full Text] [Related]
5. [Microenvironment effect of APA microcapsule on embryonic stem cell].
Wang XL; Wang W; Ma J; Guo X; Yu XJ; Qiu ZW; Ma XJ
Sheng Li Xue Bao; 2005 Dec; 57(6):766-71. PubMed ID: 16344904
[TBL] [Abstract][Full Text] [Related]
6. Release behaviors of porous poly(butylene succinate)/poly(epsilon-caprolactone) microcapsules containing indomethacin.
Park SJ; Lee YM; Hong SK
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):211-5. PubMed ID: 16413177
[TBL] [Abstract][Full Text] [Related]
7. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics.
Koch S; Schwinger C; Kressler J; Heinzen Ch; Rainov NG
J Microencapsul; 2003; 20(3):303-16. PubMed ID: 12881112
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin.
Park SJ; Kim KS; Kim SH
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):238-44. PubMed ID: 15979289
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules.
De Castro M; Orive G; Hernández RM; Bartkowiak A; Brylak W; Pedraz JL
J Biomed Mater Res A; 2009 Dec; 91(4):1119-30. PubMed ID: 19145624
[TBL] [Abstract][Full Text] [Related]
10. Characterization and release behaviors of porous PCL/Eudragit RS microcapsules containing tulobuterol.
Kim KS; Park SJ
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):404-9. PubMed ID: 20034769
[TBL] [Abstract][Full Text] [Related]
11. Microfabricated airflow nozzle for microencapsulation of living cells into 150 micrometer microcapsules.
Sugiura S; Oda T; Aoyagi Y; Matsuo R; Enomoto T; Matsumoto K; Nakamura T; Satake M; Ochiai A; Ohkohchi N; Nakajima M
Biomed Microdevices; 2007 Feb; 9(1):91-9. PubMed ID: 17106639
[TBL] [Abstract][Full Text] [Related]
12. Bioactivity improvement of poly(epsilon-caprolactone) membrane with the addition of nanofibrous bioactive glass.
Lee HH; Yu HS; Jang JH; Kim HW
Acta Biomater; 2008 May; 4(3):622-9. PubMed ID: 18171636
[TBL] [Abstract][Full Text] [Related]
13. A novel 3-D model for cell culture and tissue engineering.
Zhang X; Xie Y; Koh CG; James Lee L
Biomed Microdevices; 2009 Aug; 11(4):795-9. PubMed ID: 19288199
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two types of alginate microcapsules on stability and biocompatibility in vitro and in vivo.
Li HB; Jiang H; Wang CY; Duan CM; Ye Y; Su XP; Kong QX; Wu JF; Guo XM
Biomed Mater; 2006 Mar; 1(1):42-7. PubMed ID: 18458385
[TBL] [Abstract][Full Text] [Related]
15. Production of cell-enclosing hollow-core agarose microcapsules via jetting in water-immiscible liquid paraffin and formation of embryoid body-like spherical tissues from mouse ES cells enclosed within these microcapsules.
Sakai S; Hashimoto I; Kawakami K
Biotechnol Bioeng; 2008 Jan; 99(1):235-43. PubMed ID: 17705234
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cellular proliferation on dense and porous PCL scaffolds.
Saşmazel HT; Gümüşderelioğlu M; Gürpinar A; Onur MA
Biomed Mater Eng; 2008; 18(3):119-28. PubMed ID: 18725692
[TBL] [Abstract][Full Text] [Related]
17. Effect of acid-base interaction between silica and fragrant oil in the PCL/PEG microcapsules.
Park SJ; Yang YJ; Lee HB
Colloids Surf B Biointerfaces; 2004 Oct; 38(1-2):35-40. PubMed ID: 15465302
[TBL] [Abstract][Full Text] [Related]
18. Microencapsulation of normal and transfected L929 fibroblasts in a HEMA-MMA copolymer.
Lahooti S; Sefton MV
Tissue Eng; 2000 Apr; 6(2):139-49. PubMed ID: 10941209
[TBL] [Abstract][Full Text] [Related]
19. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
20. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]